Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.
Simpson RC, Shanahan ER, Batten M, Reijers ILM, Read M, Silva IP, Versluis JM, Ribeiro R, Angelatos AS, Tan J, Adhikari C, Menzies AM, Saw RPM, Gonzalez M, Shannon KF, Spillane AJ, Velickovic R, Lazar AJ, Damania AV, Mishra AK, Chelvanambi M, Banerjee A, Ajami NJ, Wargo JA, Macia L, Holmes AJ, Wilmott JS, Blank CU, Scolyer RA, Long GV. Simpson RC, et al. Nat Med. 2022 Nov;28(11):2344-2352. doi: 10.1038/s41591-022-01965-2. Epub 2022 Sep 22. Nat Med. 2022. PMID: 36138151
Targeting the Microbiome to Overcome Resistance.
Simpson RC, Shanahan E, Scolyer RA, Long GV. Simpson RC, et al. Cancer Cell. 2021 Feb 8;39(2):151-153. doi: 10.1016/j.ccell.2021.01.016. Cancer Cell. 2021. PMID: 33561397 Free article.
Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement.
Simpson RC, Kirtschig G, Selk A, von Seitzberg S, Vittrup G, Bissonnette I, Kottner J, Lanthier J, Stanton C, Foster D, Promm M, Augenti A, Lauretti S, Thomas KS; Core Outcomes for Research in Lichen Sclerosus (CORALS) initiative steering group. Simpson RC, et al. Br J Dermatol. 2023 Apr 20;188(5):628-635. doi: 10.1093/bjd/ljac145. Br J Dermatol. 2023. PMID: 36702803
Safety of tralokinumab in atopic dermatitis.
Simpson RC. Simpson RC. Br J Dermatol. 2023 Mar 30;188(4):e25-e26. doi: 10.1093/bjd/ljad007. Br J Dermatol. 2023. PMID: 36702801 No abstract available.
83 results